Squamous cell carcinoma (SCC), adenocarcinoma (AC), and adenosquamous carcinoma (ASC) are the most common histological subtypes of cervical cancer. Differences in the somatic mutation profiles of these subtypes have been suggested. We investigated the prevalence of somatic hot-spot mutations in three well-defined cohorts of SCC, AC, and ASC and determined the additional value of mutation profiling in predicting disease outcome relative to well-established prognostic parameters.Clinicopathological data were collected for 301 cervical tumors classified as SCC (n=166), AC (n=55), or ASC (n=80). Mass spectrometry was used to analyze 171 somatic hot-spot mutations in 13 relevant genes.In 103 (34%) tumors, 123 mutations were detected (36% in SCC,...
Human papillomavirus (HPV)-associated cervical cancer is a leading cause of cancer deaths in women. ...
OBJECTIVE: ERBB2 mutations have been found in a subset of invasive cervical cancer (ICC). Neverthel...
Background: An increasing number of anti-cancer therapeutic agents target specific mutant proteins t...
The most frequently diagnosed histological types of cervical cancer (CC) are squamous cell carcinoma...
Despite recent advances in the prevention of cervical cancer, the disease remains a leading cause of...
Objective To investigate the prevalence of somatic mutations in Indonesian cervical carcinoma patien...
<div><p>There are very few reports that describe the mutational landscape of cervical cancer, one of...
There are very few reports that describe the mutational landscape of cervical cancer, one of the lea...
International audienceCancer treatment is facing major evolution since the advent of targeted therap...
International audienceCancer treatment is facing major evolution since the advent of targeted therap...
International audienceCancer treatment is facing major evolution since the advent of targeted therap...
ObjectiveTo elucidate tumor mutation profiles associated with outcomes of uterine cervical cancer (U...
Human papillomavirus (HPV)-associated cervical cancer is a leading cause of cancer deaths in women. ...
Human papillomavirus (HPV)-associated cervical cancer is a leading cause of cancer deaths in women. ...
Adenosquamous carcinoma (ASC) is a relatively uncommon histological subtype of cervical cancer (CC)....
Human papillomavirus (HPV)-associated cervical cancer is a leading cause of cancer deaths in women. ...
OBJECTIVE: ERBB2 mutations have been found in a subset of invasive cervical cancer (ICC). Neverthel...
Background: An increasing number of anti-cancer therapeutic agents target specific mutant proteins t...
The most frequently diagnosed histological types of cervical cancer (CC) are squamous cell carcinoma...
Despite recent advances in the prevention of cervical cancer, the disease remains a leading cause of...
Objective To investigate the prevalence of somatic mutations in Indonesian cervical carcinoma patien...
<div><p>There are very few reports that describe the mutational landscape of cervical cancer, one of...
There are very few reports that describe the mutational landscape of cervical cancer, one of the lea...
International audienceCancer treatment is facing major evolution since the advent of targeted therap...
International audienceCancer treatment is facing major evolution since the advent of targeted therap...
International audienceCancer treatment is facing major evolution since the advent of targeted therap...
ObjectiveTo elucidate tumor mutation profiles associated with outcomes of uterine cervical cancer (U...
Human papillomavirus (HPV)-associated cervical cancer is a leading cause of cancer deaths in women. ...
Human papillomavirus (HPV)-associated cervical cancer is a leading cause of cancer deaths in women. ...
Adenosquamous carcinoma (ASC) is a relatively uncommon histological subtype of cervical cancer (CC)....
Human papillomavirus (HPV)-associated cervical cancer is a leading cause of cancer deaths in women. ...
OBJECTIVE: ERBB2 mutations have been found in a subset of invasive cervical cancer (ICC). Neverthel...
Background: An increasing number of anti-cancer therapeutic agents target specific mutant proteins t...